Yantai Dongcheng Pharmaceutical Group Co., Ltd.

About Yantai Dongcheng Pharmaceutical Group Co., Ltd.

A Other / Uncategorized player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• BioPharma Reporter · 2026-02-03
  Yantai Dongcheng Pharmaceutical Group Co Ltd publishes dosimetry data at SNMMI 2026
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• FierceBiotech · 2026-09-24
  Yantai Dongcheng Pharmaceutical Group Co Ltd closes Series C round to scale radiopharma manufacturing
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Endpoints News · 2026-12-05
  Yantai Dongcheng Pharmaceutical Group Co Ltd partners with academic center on Actinium-225 program
  Coverage notes the company's growing footprint in the radioligand therapy space.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.